Description
Bellast Prime Hard is a CE-marked hyaluronic acid (HA) dermal filler from the Bellast Prime range by Fox Pharma. It is formulated with a high-density cross-linked HA (24 mg/ml) and 0.3% lidocaine, creating a viscous gel with uniform particles designed for deep dermal injection. The high viscoelasticity and gel density of Bellast Prime Hard provide structural support and volumising effect, restoring lost facial volume and contour. The filler is bio-absorbable, gradually metabolised by endogenous hyaluronidases over time. Indications include correction of deeper wrinkles/folds and facial contouring in areas requiring significant volume or definition (e.g., nasolabial folds, cheeks, chin, jaw).
What Bellast Prime Hard Is Similar To
Bellast Prime Hard can be compared to other high-density HA fillers used for deep dermal or subdermal augmentation, such as Restylane® (or other thicker HA fillers designed for cheeks, chin, or nasolabial folds). Like Restylane and similar fillers, Bellast Prime Hard uses cross-linked HA to provide structural support, volume restoration, and skin contouring. The 24 mg/ml HA concentration and robust viscoelastic gel of Bellast Prime Hard offer volume retention and support comparable to well-established deep fillers. However, differences may arise in gel rheology, particle size, and clinical handling — potentially affecting gel integration, mouldability, and longevity. This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
-
Nasolabial folds
-
Cheeks (malar area)
-
Chin
-
Jaw / jawline contouring
Usage / Administration (IFU-based)
-
Delivery form: 1 × 1 ml prefilled syringe.
-
Needles included: 25G and 27G sterile needles.
-
Injection depth: as per manufacturer, “deep dermis” for Bellast Prime Hard.
-
Volume per point / injection site: not provided by manufacturer.
-
Frequency / number of sessions: not provided by manufacturer.
Professional-use disclaimer: Administered only by qualified medical professionals under aseptic conditions.
Note: If a practitioner uses different techniques (e.g., cannula, layering, micro-bolus), these are not part of the official manufacturer’s IFU.
Ingredient List
-
Hyaluronic acid, cross-linked — 24 mg/mL
-
Lidocaine — 0.3%
-
Excipients / buffer / carrier gel: not specified in public documentation
Presentation & Longevity
-
Packaging: 1 × 1.0 ml prefilled syringe (ergonomic design) with 1 × 25G needle and 1 × 27G needle included
-
Shelf-life or expiry: not provided by manufacturer (publicly available).
-
Expected duration of clinical effect: between 6 and 12 months after injection.
Safety Notes / Contraindications
According to the manufacturer:
-
Do not use in patients with bleeding disorders or those on medication affecting platelet function.
-
Not to be resterilised or mixed with other products before injection.
-
Not recommended for patients prone to keloid formation or with active inflammation / infection at the injection site.
-
Contraindicated in individuals with known lidocaine allergy.
-
Not advised in pregnancy or breastfeeding.
Standard caution (if not otherwise specified): Additional contraindications may include active skin infections, autoimmune or immunosuppressive conditions, and recent dental/dermal procedures; full medical history and consultation required prior to treatment.
Regulatory Status
-
CE-marked medical device.
-
UKCA status not explicitly stated — verify via IFU or distributor at time of purchase.
FAQ
Q1: What makes Bellast Prime Hard different from other HA fillers?
A1: Bellast Prime Hard combines a high concentration of cross-linked HA (24 mg/ml) with a viscous, high-density gel formulation — resulting in increased viscoelasticity and structural support. This makes it especially suitable for deep dermal injection to restore volume, contour cheeks/chin/jaw, and correct deep folds.
Q2: How long will the results of Bellast Prime Hard last?
A2: According to the manufacturer, visible aesthetic results can last between 6 and 12 months. However, longevity can vary depending on factors such as injection technique, patient metabolism, lifestyle, and treatment area.
Q3: Is the injection of Bellast Prime Hard painful?
A3: The filler contains 0.3% lidocaine, a local anaesthetic, which helps reduce discomfort during injection.As with all dermal filler procedures, patients may still experience some mild stinging or pressure, but overall pain is generally minimised.
Q4: Can Bellast Prime Hard filler be reversed when needed?
A4: Since Bellast Prime Hard is HA-based, like other HA dermal fillers, it is biocompatible and bio-absorbable. In most clinical practice, HA fillers can be dissolved using hyaluronidase if required (though the manufacturer’s IFU should be consulted for compatibility).
Q5: What are the main risks or complications associated with HA fillers like Bellast Prime Hard?
A5: Common mild adverse effects include swelling, bruising, redness, tenderness, or lumps immediately after injection.In rare cases, more serious complications such as vascular occlusion (which may lead to skin necrosis or, very rarely, vision loss) have been reported especially in high-risk injection zones or with improper technique. It is critical that injections are performed by trained medical professionals with full knowledge of facial anatomy and safety protocols.
